NVIC.org (@NVIC)

FDA Leadership’s “Blind Spots” Lead to a Surge in Medical Device and Drug Recalls | TVR | David Gortler, Pharm. D | https://ow.ly/l1vY50Zjt0v 🔹FDA “Remote” and “Announced” Inspections Began During Covid… But Never Stopped 🔹China and India Manufacturing Quality 🔹Delayed Messaging to Patients by FDA 🔹Blind Trust on Complex FDA Devices and Other Products 🔹FDA-Regulated Device Recalls 🔹The Current FDA Inspection Policy Isn’t Adequately Protecting Americans #FDA #DrugRecalls #PatientSafety #MedicalDeviceRecall #NVIC